ImmunityBio stock jumps after strong trial updates in bladder cancer and lymphoma, with enrollment ahead of schedule and FDA ...

Segment 6 focuses on decision-making in second-line therapy for cGVHD, centering on the role of ruxolitinib. Dr. DeFilipp ...

AXS-14 (esreboxetine) is a highly selective and potent norepinephrine reuptake inhibitor being developed for the management of fibromyalgia. Esreboxetine is the SS-enantiomer of racemic reboxetine.

Treatment with biologic DMARDs vs standard therapy improved clinical response rates and flare outcomes among patients with polyarticular JIA.

New research shows yoga helps individuals in rehab for opioid addiction recover more quickly and with decreased cravings, ...

The decision was based on an interim analysis of the phase 3 Opera-T study, conducted after around half of the patients had ...

FDA removes black box warnings for most MHT products, reflecting evidence that breast cancer risk varies by formulation, ...

A new clinical study published in the International Journal of Gynecological Cancer reports encouraging results for women ...

Supraglottic airway (SGA) devices used for out-of-hospital cardiac arrest (OHCA) were more successful at first attempt, but ...

The presence of circulating tumor DNA (ctDNA) in patients with human epidermal growth factor receptor 2 (HER2)-positive ...

Seasonal affective disorder (SAD) is a real condition that often strikes during the colder months. Discover how CBT ...

Eating a low-carb breakfast can prevent post-breakfast blood sugar spikes, compared to breakfasts high in sugary and ...